Colgate-Palmolive Company (CL) earnings on July 31, 2026

Before the market opens Q2 2026

More Colgate-Palmolive Company earnings

Prior outlook: No statistical edge

Colgate-Palmolive beat profit and sales estimates, but the stock fell 0.5% after a warning that new tariffs could offset a recent refund. The stock had risen as much as 1.9% earlier.

CL price around the earnings

91.30

Change: -0.3%

2026-07-31, 20:00 UTC

Start of the measured window End of the measured window
89.00 90.41 91.82 93.23 91.54
Price series around the eventClosing price per minute from before the event to the end of the measured window.
July 31, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • End of the measured window
  • Market open
  • Starting price
Price series around the event

Prior thesis

Prior outlook: No statistical edge

Thesis published
Results released

Weak trend strength (-2.60% 14d) offset by a strong recent earnings history (100% beat) and optimistic analyst ratings; pullback after prior run-up creates a mixed scenario.

Context analyzed before publication

Trend
Peaked 7/30 at 36.9, collapsed to 3.4 on event day — sharp trajectory decline into earnings with post-runup pullback con

Analysts

Evidence

Analyst consensus
Buy
Consensus average (1-5)
2.1
Analysts covering the stock
20
Average price target
97.65
Lowest price target
85
Highest price target
110
Upside to price target
6.6%
Quarterly earnings growth
-6.4%
Revenue growth
8.4%
Forward EPS
4.05
Trailing EPS
2.53
Analyst moves in the last 60 days
7
  • Strong buy: 6
  • Buy: 7
  • Hold: 7
  • Sell: 0
  • Strong sell: 1
Strong buy
6
Buy
7
Hold
7
Sell
0
Strong sell
1
  • July 21, 2026 · Barclays: Maintains rating (Equal-Weight → Equal-Weight)
  • July 16, 2026 · JP Morgan: Maintains rating (Overweight → Overweight)
  • July 16, 2026 · UBS: Maintains rating (Buy → Buy)
  • July 14, 2026 · Citigroup: Maintains rating (Buy → Buy)
  • July 9, 2026 · Piper Sandler: Maintains rating (Overweight → Overweight)
  • July 8, 2026 · Wells Fargo: Maintains rating (Equal-Weight → Equal-Weight)
  • June 11, 2026 · Bernstein: Initiates coverage (Market Perform)

News and sentiment

Evidence

Sentiment
Sentiment
Constructive
Mention volume
Low
Normalized volume
33%
News
Sources (8)

Technicals

Evidence

Price when the context was analyzed
91.62
Average true range (ATR)
2.7%
Distance to 52-week high
-6.5%
14-day change (14d)
-2.6%
30-day change (30d)
-0.0%
30-day relative strength
+0.6%
SPY change (30d)
-0.7%
Nearest support
91.43
Distance to nearest support
0.2%
Nearest resistance
91.88
Distance to nearest resistance
0.3%
Volume accumulation ratio (14d / 46d)
0.76
  • Major: 91.43 (0.2% away, 0.07 ATR, 65 touches)
  • Major: 90.57 (1.1% away, 0.42 ATR, 49 touches)
  • Major: 90.06 (1.7% away, 0.63 ATR, 45 touches)
  • Major: 91.88 (0.3% away, 0.1 ATR, 42 touches)
  • Major: 93.1 (1.6% away, 0.6 ATR, 54 touches)
  • Major: 94 (2.6% away, 0.97 ATR, 55 touches)

Trends

Evidence

Average earnings surprise
+3.0%
  • May 1, 2026: actual EPS 0.97 vs estimate 0.94 (surprise +2.7%)
  • January 30, 2026: actual EPS 0.95 vs estimate 0.91 (surprise +4.2%)
  • October 31, 2025: actual EPS 0.91 vs estimate 0.89 (surprise +2.4%)
  • August 1, 2025: actual EPS 0.92 vs estimate 0.89 (surprise +2.8%)

Expected move

Implied move
+0.1%
Source
Options chain

Reactions over its last 20 earnings

Median move
2%
75th percentile move
4.3%
90th percentile move
5%
Up / down moves
10 / 10
Average up move
+2.2%
Average down move
-3.0%

Monitoring and close

What Colgate-Palmolive Company reported

Status
Finished
Actual EPS0.99
EPS estimate0.95
EPS surprise+4.2%
Revenue$5,361 million
Revenue estimate$5,358 million
Revenue surprise+0.1%

Colgate Q2 earnings beat estimates with 4.9% sales growth, strong margins and Latin America leading regional gains. Tariffs still weigh on outlook, shares rose pre-market.

Sources (15)

Pre-market second reading after the results

Verdict
Beat expectations

Heading into the open, the results beat expectations on both earnings and revenue, and the price is indicating -1.8% pre-market, a move in line with the stock's usual reaction (about 2%). The figures don't confirm the prior scenario: there was no prior directional scenario to check against.

How the stock reacted

Consolidated
-0.5%
Max move
-2.4%

No verdict: the outlook took no direction, so there is nothing to score as a hit or a miss.